Frontida BioPharm

Frontida Biopharm, an affiliate of Frontage Laboratories, is a contract development and manufacturing organization that collaborates with clients to bring new and improved products to the pharmaceutical market, supporting biopharmaceutical companies in scaling up and commercializing the production of immediate and controlled-release oral solid dosage formulations. Frontida offers capabilities in manufacturing highly potent active ingredient products, combination products, and DEA Schedule II - V products. Its proprietary Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better-engineered and lower-cost controlled-release products.